Summary
- Current Price
- As of today, INM price is $1.72, down -0.58% on
- Current Price All-Time High
- INM price is currently -99.99% below its historical high of $32,175.00 set on
- Market Cap
- INM current market cap is $6M, up +71.70% over the past 365 days
- PE Ratio
- INM PE ratio is unknown
- Revenue
- INM current annual revenue is $4.94M, up +7.50% year-over-year
- Next Earnings
- As of today, the next earnings release for INM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | InMed Pharmaceuticals Inc. |
| Ticker | NASDAQ: INM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | inmedpharma.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.72 | ||
| Price, 1D Change | -0.58% | |
| $6M | ||
| - | ||
| - | ||
| 1.08 | ||
| $5M | ||
| Revenue, 1Y Change | +7.50% | |
| -$8.36 | ||
| EPS, 1Y Change | +58.48% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$8.36 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $4.94M | ||
| Revenue Estimate | N/A | $71.00M |
| Revenue Est. Change | N/A | +1,336.49% |
| $1.72 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$64.92 | - | |
| - | -$20.14 | - | |
| - | -$8.36 | - | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.13M | $4.14M | +0.14% | |
| $5.42M | $4.60M | -15.17% | |
| $6.77M | $4.94M | -26.99% | |
| $71.00M | N/A | +1,336.49% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -37.45% | ||
| -93.86% | ||
| +71.70% | ||
| +22.34% | ||
| +7.50% | ||
| +353.70% | ||
| +58.48% | ||
| +99.95% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $1.72 | ||
| $1.39 | ||
| SMA 200 vs Price | -19.17% | |
| $0.79 | ||
| SMA 50 vs Price | -54.08% | |
| 1.08 | ||
| $0.17 | ||
| 87.53 | ||
| 673.45% | ||
| 170.53% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $4.94M | ||
| -$8.36 | ||
| $1.17M | ||
| 23.71% | ||
| -$7.92M | ||
| -160.20% | ||
| -$8.16M | ||
| -165.14% | ||
| -$7.38M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.06 | ||
| 6.99 | ||
| 6.47 | ||
| - | ||
| - | ||
| -9.45 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1.76 | ||
| 0.83 | ||
| -0.12 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $13.43M | ||
| $11.12M | ||
| $15.58M | ||
| $12.87M | ||
| $2.15M | ||
| $1.84M | ||
| $741.30K | ||
| $435.50K | ||
| $370.10K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $13.10M | ||
| $9.09M | ||
| $3.77M | ||
| $0.00 | ||
| $534.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$7.77M | ||
| $0.00 | ||
| $12.27M | ||
| $0.00 | ||
| -$7.77M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| Roth Capital |
Analyst sentiment
Institutional ownership
Screeners with INM
FAQ
What is the ticker symbol for InMed Pharmaceuticals Inc.?
The ticker symbol for InMed Pharmaceuticals Inc. is NASDAQ:INM
Does InMed Pharmaceuticals Inc. pay dividends?
No, InMed Pharmaceuticals Inc. does not pay dividends
What sector is InMed Pharmaceuticals Inc. in?
InMed Pharmaceuticals Inc. is in the Healthcare sector
What industry is InMed Pharmaceuticals Inc. in?
InMed Pharmaceuticals Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is InMed Pharmaceuticals Inc. based in?
InMed Pharmaceuticals Inc. is headquartered in Canada
When did InMed Pharmaceuticals Inc. go public?
InMed Pharmaceuticals Inc. initial public offering (IPO) was on May 5, 2014
Is InMed Pharmaceuticals Inc. in the S&P 500?
No, InMed Pharmaceuticals Inc. is not included in the S&P 500 index
Is InMed Pharmaceuticals Inc. in the NASDAQ 100?
No, InMed Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is InMed Pharmaceuticals Inc. in the Dow Jones?
No, InMed Pharmaceuticals Inc. is not included in the Dow Jones index
When was InMed Pharmaceuticals Inc. last earnings report?
InMed Pharmaceuticals Inc.'s most recent earnings report was on September 30, 2025
When does InMed Pharmaceuticals Inc. report earnings?
The date for InMed Pharmaceuticals Inc.'s next earnings report has not been announced yet
Data Sources & References
- INM Official Website www.inmedpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1728328/000121390025090210/0001213900-25-090210-index.htm
- INM Profile on Yahoo Finance finance.yahoo.com/quote/INM
- INM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/inm